Search results for "intestinal metaplasia"

showing 10 items of 20 documents

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), Europea…

2019

Main RecommendationsPatients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma. This underscores the importance of diagnosis and risk stratification for these patients. High definition endoscopy with chromoendoscopy (CE) is better than high definition white-light endoscopy alone for this purpose. Virtual CE can guide biopsies for staging atrophic and metaplastic changes and can target neoplastic lesions. Biopsies should be taken from at least two topographic sites (antrum and corpus) and labelled in two separate vials. For patients with mild to moderate atrophy restricted to the antrum there is no evidence to recommend surveillance. In pati…

Gastritis Atrophicmedicine.medical_specialtyAtrophic gastritisBiopsyChronic gastritisgastroenterologyGastroenterologyRisk AssessmentEndoscopy GastrointestinalChromoendoscopyHelicobacter Infections03 medical and health sciences0302 clinical medicineStomach Neoplasmsgastroenterology; precancerous conditions; stomach; gastric cancerInternal medicinemedicineHumansprecancerous conditionsMetaplasiamedicine.diagnostic_testbusiness.industryStomachgastric cancerIntestinal metaplasiamedicine.diseaseEndoscopyPatient Care ManagementEuropemedicine.anatomical_structureDysplasia030220 oncology & carcinogenesis030211 gastroenterology & hepatologyGastritismedicine.symptombusinessstomach
researchProduct

Endoscopic assessment and grading of Barrett's esophagus using magnification endoscopy and narrow-band imaging: accuracy and interobserver agreement …

2010

Background: Three different classification systems for the evaluation of Barrett's esophagus (BE) using magnification endoscopy (ME) and narrow-band imaging (NBI) have been proposed. Until now, no comparative and external evaluation of these systems in a clinical-like situation has been performed. Objective: To compare and validate these 3 classification systems. Design: Prospective validation study. Setting: Tertiary-care referral center. Nine endoscopists with different levels of expertise from Europe and Japan participated as assessors. Patients: Thirty-two patients with long-segment BE. Interventions: From a group of 209 standardized prospective recordings collected on BE by using …

Malemedicine.medical_specialtyBarrett EsophagusSDG 3 - Good Health and Well-beingPredictive Value of TestsmedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesEsophagusGrading (tumors)AgedObserver VariationNarrow-band imagingMucous Membranebusiness.industryGastroenterologyIntestinal metaplasiaMiddle Agedmedicine.diseaseGastric typeImage EnhancementMagnification endoscopySurgerymedicine.anatomical_structureDysplasiaBarrett's esophagusFemaleRadiologyEsophagoscopybusinessPrecancerous ConditionsGastrointestinal Endoscopy
researchProduct

The accuracy of flexible spectral imaging colour enhancement for the diagnosis of gastric intestinal metaplasia

2014

Background Targeting biopsies on the basis of visual recognition of mucosal changes in the stomach instead of the currently accepted random biopsy sampling may be attractive. Aim The aim of this study was to evaluate the accuracy of endoscopic findings using flexible spectral imaging colour enhancement (FICE) for intestinal metaplasia (IM) in the gastric mucosa. Methods A consecutive cohort of 126 individuals aged over 50 years (27% men) was subjected to upper endoscopy using FICE. Histological assessment (per patient and per biopsy) was considered the gold standard to accuracy estimates. Results Histological assessment revealed IM in 50% of the individuals [OLGIM (operative link on gastric…

Malemedicine.medical_specialtyBiopsyAdenocarcinomaRisk AssessmentSensitivity and SpecificityGastroenterologyLikelihood ratios in diagnostic testingStomach NeoplasmsInternal medicineGastroscopyBiopsymedicineHumansSampling (medicine)AgedAged 80 and overMetaplasiaHepatologymedicine.diagnostic_testbusiness.industryStomachGastroenterologyReproducibility of ResultsIntestinal metaplasiaGold standard (test)Middle AgedImage Enhancementmedicine.diseaseConfidence intervalEndoscopymedicine.anatomical_structureGastric MucosaColorimetryFemalebusinessPrecancerous ConditionsEuropean Journal of Gastroenterology & Hepatology
researchProduct

Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy.

2013

Background Either atrophy or intestinal metaplasia of the gastric mucosa are considered premalignant lesions. The new operative link for gastritis assessment staging system is based on the detection of atrophy, and the operative link for assessment of intestinal metaplasia staging system is based on the detection of intestinal metaplasia. Good interobserver agreement is necessary for identification of any premalignant condition. Aims The aim of this study was to compare the agreement between findings of gastric atrophy and intestinal metaplasia by expert and general pathologists and to analyze the possible reasons behind any possible disagreement. Methods Patients with dyspeptic symptoms, a…

Malemedicine.medical_specialtyBiopsyGastroenterologySeverity of Illness IndexAtrophyStomach NeoplasmsInternal medicineMetaplasiaBiopsymedicineGastric mucosaHumansAntrumAgedObserver VariationMetaplasiaHepatologybiologymedicine.diagnostic_testbusiness.industryGastroenterologyIntestinal metaplasiaHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureGastric MucosaFemaleClinical Competencemedicine.symptomGastritisAtrophybusinessPrecancerous ConditionsEuropean journal of gastroenterologyhepatology
researchProduct

The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions.

2017

Abstract Background: Serum autoantibodies against tumor-associated antigens (TAAs) are detectable in early-stage gastric cancer patients; however, the time point during cancerogenesis when they appear in circulation is still obscure. Methods: In this study, we developed a recombinant antigen microarray and analyzed the prevalence of autoantibodies against 102 TAAs in 829 gastric cancer patients and 929 healthy controls from Caucasian and Asian populations, as well as 100 patients with chronic atrophic gastritis and 775 individuals staged according to different grades of intestinal metaplasia. Results: Six antigens, including CTAG1B/CTAG2, DDX53, IGF2BP2, TP53, and MAGEA3, were predominantly…

Malemedicine.medical_specialtyMAGEA3EpidemiologyAtrophic gastritisGastroenterology03 medical and health sciences0302 clinical medicineAntigenStomach NeoplasmsInternal medicinemedicinePrevalenceHumansAutoantibodiesbiologybusiness.industryStomachAutoantibodyIntestinal metaplasiaCancerHelicobacter pyloriMiddle Agedmedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureOncology030220 oncology & carcinogenesisImmunology030211 gastroenterology & hepatologyFemaleNeoplasm GradingbusinessPrecancerous ConditionsCancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
researchProduct

Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus

2014

Intestinal metaplasia in Barrett’s oesophagus (BO) represents an important risk factor for oesophageal adenocarcinoma. Instead, few and controversial data are reported about the progression risk of columnar-lined oesophagus without intestinal metaplasia (CLO), posing an issue about its clinical management. The aim was to evaluate if some immunophenotypic changes were present in CLO independently of the presence of the goblet cells. We studied a series of oesophageal biopsies from patients with endoscopic finding of columnar metaplasia, by performing some immunohistochemical stainings (CK7, p53, AuroraA) combined with histochemistry (Alcian-blue and Alcian/PAS), with the aim of simultaneousl…

Mild Dysplasiap53MalePathologymedicine.medical_specialtyHistologyEsophageal NeoplasmsBiophysicsSettore MED/08 - Anatomia PatologicaBiologyAdenocarcinomadigestive systemBarrett EsophagusEsophagusAntigenMetaplasiamedicineHumansEsophaguslcsh:QH301-705.5Retrospective StudiesMetaplasiaStaining and LabelingBrief ReportBarrett’s oesophagusIntestinal metaplasiaCell Biologymedicine.diseaseImmunohistochemistryEpitheliumdigestive system diseasesBarrett’s oesophagus columnar-lined oesophagus p53 Aurora A kinasemedicine.anatomical_structureBarrett’s oesophagus columnar-lined oesophagus p53 Aurora A kinase.lcsh:Biology (General)columnar-lined oesophagusAdenocarcinomaImmunohistochemistryAurora A kinaseFemaleGoblet Cellsmedicine.symptomEuropean Journal of Histochemistry
researchProduct

Is Helicobacter pylori status relevant in the management of GORD?

2000

Summary There is growing interest in the relationship between H. pylori infection and gastro-oesophageal reflux disease (GORD). However, this relationship is complex, as yet not fully elucidated, and probably based on a multiplicity of factors. The prevalence of H. pylori infection in patients with GORD is similar, more often lower than in matched controls. There is a negative correlation between H. pylori infection and the severity of GORD. There are many hypothetical mechanisms by which H. pylori infection may protect from the development of GORD. Conversely, there are many possible mechanisms by which H. pylori infection could theoretically foster the GORD. Patients after H. pylori eradi…

medicine.medical_specialtyAtrophic gastritismedicine.drug_classProton-pump inhibitordigestive systemGastroenterologyInternal medicinemedicinePharmacology (medical)HelicobacterHepatologybiologybusiness.industryStomachdigestive oral and skin physiologyGastroenterologyIntestinal metaplasiaHelicobacter pylorimedicine.diseasebiology.organism_classificationdigestive system diseasesmedicine.anatomical_structureDysplasiaGastritismedicine.symptombusinessAlimentary Pharmacology & Therapeutics
researchProduct

Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus

2002

Aim: To assess the oesophageal manometric characteristics and 24-h pH profiles of patients with both short-segment and long-segment Barrett's oesophagus and compare them with those of patients with reflux oesophagitis and controls. Methods: Seventy-nine patients who had undergone upper digestive endoscopy were recruited: 16 had short-segment Barrett's oesophagus, 13 had long-segment Barrett's oesophagus, 25 had grade III oesophagitis according to the Savary–Miller classification and 25 were used as controls. The diagnosis of Barrett's oesophagus was based on the histological detection of specialized intestinal metaplasia, which extended  3 cm in patients with long-segment disease. All subje…

medicine.medical_specialtyHepatologybusiness.industryEsophageal diseasedigestive oral and skin physiologyGastroenterologyCase-control studyRefluxIntestinal metaplasiaLong segmentmedicine.diseasedigestive systemGastroenterologydigestive system diseasesPathophysiologymedicine.anatomical_structureInternal medicineotorhinolaryngologic diseasesmedicinePharmacology (medical)EsophagusbusinessEsophagitisAlimentary Pharmacology & Therapeutics
researchProduct

Systematic review of the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies

2013

Aim. The aim of the article is to systematically review the current evidence on the diagnostic use of narrow band imaging (NBI), flexible spectral imaging color enhancement (FICE) and endoscopic image enhancement technology i-scan endoscopies for gastric precancerous and cancerous lesions. Materials and methods. Original manuscripts were searched in PubMed until October 2012. Pertinent data were collected and pooled diagnostic accuracy measures were estimated when possible. Results. In total, 38 studies were evaluated. Thirty-one studies were included for NBI and 7 studies for FICE assessment in this systematic review. No article was found meeting inclusion criteria for i-scan endoscopy. Th…

medicine.medical_specialtyHigh resolutionAdenocarcinomaSensitivity and SpecificityGastroenterologyNarrow Band ImagingStomach NeoplasmsInternal medicineGastroscopymedicineHumansObserver VariationModels StatisticalNarrow-band imagingmedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsIntestinal metaplasiaImage Enhancementmedicine.diseaseEndoscopyGastric MucosaDysplasiaColor enhancementDiagnostic odds ratioRadiologybusinessPrecancerous ConditionsEndoscopic imageScandinavian Journal of Gastroenterology
researchProduct

Expression of Cytokeratin 7 and 20 in Pathological Conditions of the Bile Tract

2003

Expression of cytokeratin 7 (CK7) and cytokeratin 20 (CK20) helps to establish the origin of biliary and metastatic carcinomas. We investigated the expression of CK7 and CK20 in inflammatory, metaplastic and neoplastic conditions of the bile ducts, and evaluated possible relationships between the CK expression pattern and extrahepatic bile duct/gallbladder carcinomas (EBDCs) or intrahepatic bile duct carcinomas (IBDCs). We used immunohistochemistry for the investigation of 48 formalin-fixed, paraffin-embedded specimens grouped as: A) lithiasic or inflamed surgically resected extrahepatic bile ducts/gallbladders: all were CK7+/CK20+; B) percutaneous liver biopsies from patients with chronic …

medicine.medical_specialtyPathologyIntestinal metaplasia2734Intrahepatic bile ductsBile duct tumors; Cytokeratin 20 (CK20); Cytokeratin 7 (CK7); Intestinal metaplasia; Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts Extrahepatic; Bile Ducts Intrahepatic; Carcinoma; Cell Transformation Neoplastic; Gallbladder Diseases; Gallbladder Neoplasms; Gene Expression Profiling; Humans; Immunohistochemistry; Intermediate Filament Proteins; Keratin-20; Keratin-7; Keratins; 2734Bile Duct DiseasesGallbladder DiseasesKeratin-20Settore MED/08 - Anatomia PatologicaGastroenterologyIntermediate Filament ProteinPathology and Forensic MedicinePrimary sclerosing cholangitisCytokeratinPrimary biliary cirrhosisIntermediate Filament ProteinsBile Ducts ExtrahepaticInternal medicineBile duct tumormedicineHumansCytokeratin 7 (CK7)Bile Duct NeoplasmGallbladder NeoplasmBile ductbusiness.industryGene Expression ProfilingGallbladderKeratin 20CarcinomaGallbladder DiseaseKeratin-7Bile Duct DiseaseCell Biologymedicine.diseaseImmunohistochemistryBile Ducts IntrahepaticCell Transformation Neoplasticmedicine.anatomical_structureBile Duct NeoplasmsKeratinKeratin 7KeratinsGallbladder NeoplasmsbusinessCytokeratin 20 (CK20)HumanPathology - Research and Practice
researchProduct